Arcus Biosciences IncRCUS
Price$25.83Intrinsic value$20.8619% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $20.86median of 2 methodsbased on filings through 30 Jun 2026
Market Price $25.83Price as of 30 Sep 2026
Margin of Safety -19.3%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 11.7%/yr (balance of the path).10.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 611.4%Yr 711.2%Yr 810.9%Yr 910.6%Yr 1010.3%
11.7% → 10.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 119.6%Yr 128.9%Yr 138.1%Yr 147.4%Yr 156.7%Yr 165.9%Yr 175.2%Yr 184.5%Yr 193.7%Yr 203.0%
10.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 8.8%
Volatility vs market (adjusted beta)0.87

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetArcus Biosciences IncRCUSHealth Care
Valuation
P/E—
P/S56.4×
P/B7.2×
EV / Revenue55.5×
EV / EBITDA4.0×
Profitability
Gross margin100.0%
Operating margin-788.2%
Net margin-807.0%
FCF margin-833.3%
Returns
ROE-99.1%
ROA-49.8%
ROIC—
Growth
Revenue growth (YoY)11.8%
5-yr fwd EPS growth10.3%
Financial strength
Debt / Equity0.22×
Current ratio3.82×
Altman Z-Score0.9
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.